Hepatocellular Carcinoma: Molecular Mechanisms, Diagnosis and Therapy

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".

Deadline for manuscript submissions: closed (20 October 2024) | Viewed by 21

Special Issue Editor


E-Mail Website
Guest Editor
Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA
Interests: liver cancer; anti-tumor drugs discovery and test; liver cancer biomarker discovery; liver diseases preventive; patient training

Special Issue Information

Dear Colleagues,

Liver cancer, with 80% of cases arising in individuals with chronic liver disease, poses a grave prognosis. A comprehensive understanding of Hepatocellular Carcinoma (HCC) pathogenesis requires an exploration of the intricacies within the chronically diseased liver—a dynamic environment fostering inflammation and stress, providing a substrate for HCC emergence. Primary liver cancers, classified as HCC and the aggressive Cholangiocarcinoma (CCA), present a challenge due to their vast heterogeneity, ranging from pure HCC to pure CCA, with the degree of cholangiocytic characteristics correlating with aggressiveness. Progression and treatment responses unveil adaptability, often resulting in resistance and amplification of cholangiocytic traits. The elusive mechanisms driving cellular plasticity and phenotypic transitions in HCC cells necessitate unraveling for effective intervention. Our Special Issue delves into hepatocellular cancer pathogenesis at the cellular and molecular levels, emphasizing diagnosis, classification, and emerging treatments. Enriching our exploration, we discuss advances in personalized medicine, exploring how molecular profiling and individualized therapies shape liver cancer management. A dedicated section explores immunotherapeutic strategies, including recent trials, successes, and challenges. Mechanisms of drug resistance are examined, alongside strategies like combination therapies and novel drug delivery methods. Integrating perspectives from basic research and clinical practice, we showcase collaborative studies bridging the gap between lab findings and real-world applications. Emphasizing patient-centric approaches, we discuss outcomes, survivorship programs, and supportive care. This concise overview captures the current state of research while spotlighting promising directions for future investigation and clinical application.

Dr. Mingdian Tan
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • liver cancer
  • hepatocellular carcinoma
  • pathogenesis
  • diagnosis
  • classification
  • treatment

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop